← Leaderboards
Jillian Marie Prendergast
Siamab Therapeutics, Inc.
$219,846
Attributed
$219,846
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$219,846 · 1
By mechanism
R43$219,846 · 1
Top collaborators
No co-investigators on record.
Most similar at Siamab Therapeutics, Inc.
Same institution · by research overlap
- Elaine Anselmo Muchmore$202,116
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAffinityAntibodiesAntibody -Dependent Cell CytotoxicityAntibody FormationAntibody ResponseAntigensAntigens, Tumor-Associated, CarbohydrateBaseBinding (Molecular Function)Breast Cancer CellBreast CarcinomaCancer CellCancer PatientCancer TherapyCarbohydratesCaringCarrier ProteinsCell KillingCell LineCell SurfaceChemotherapeutic AgentClinical MaterialAdult